TOCQUEVILLE ASSET MANAGEMENT L.P. - NEUBASE THERAPEUTICS INC ownership

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 48 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$17,000
-69.6%
42,500
-20.6%
0.00%
-100.0%
Q2 2022$56,000
-44.6%
53,5000.0%0.00%
-50.0%
Q1 2022$101,000
-32.7%
53,5000.0%0.00%0.0%
Q4 2021$150,000
-43.8%
53,500
-27.7%
0.00%
-50.0%
Q3 2021$267,000
+93.5%
74,000
+156.9%
0.00%
+100.0%
Q2 2021$138,000
-59.9%
28,800
-38.1%
0.00%
-60.0%
Q1 2021$344,000
-5.5%
46,550
-10.6%
0.01%
-16.7%
Q4 2020$364,000
+136.4%
52,050
+155.8%
0.01%
+100.0%
Q3 2020$154,00020,3500.00%
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Greenlight Capital 2,027,027$14,169,0000.85%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 103,500$723,0000.55%
Sio Capital Management, LLC 293,699$2,053,0000.42%
GSA CAPITAL PARTNERS LLP 121,389$849,0000.14%
Frontier Wealth Management LLC 145,000$1,014,0000.08%
PRELUDE CAPITAL MANAGEMENT, LLC 311,000$2,174,0000.06%
Oak Grove Capital LLC 19,175$134,0000.04%
PREMIER ASSET MANAGEMENT LLC 14,977$105,0000.02%
Trexquant Investment LP 15,479$108,0000.01%
PILLAR PACIFIC CAPITAL MANAGEMENT LLC 19,800$138,0000.01%
View complete list of NEUBASE THERAPEUTICS INC shareholders